Cleared Special

K172073 - Hi-Torque Command 18 Guide Wire

K172073 is an FDA 510(k) clearance for Hi-Torque Command 18 Guide Wire, manufactured by Abbott Vascular. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Special 510(k) pathway after a 46-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
46d
Days
Class 2
Risk

K172073 is an FDA 510(k) clearance for the Hi-Torque Command 18 Guide Wire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Abbott Vascular (Santa Clara, US). The FDA issued a Cleared decision on August 25, 2017 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Abbott Vascular devices

FDA 510(k) Submission Details - K172073

510(k) Number K172073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2017
Decision Date August 25, 2017
Days to Decision 46 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 125d · This submission: 46d
Pathway characteristics
Modification to existing cleared device.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 681
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K172073.
WATCHDOG Hemostasis Valve Kit
K172453 · Boston Scientific Corporation · Nov 2017
Heraeus TMW Guidewire
K173052 · Heraeus Medical Components, LLC · Oct 2017
Glidewire GT
K170417 · Terumo Corporation · Sep 2017
Approach CTO Microwire Guide
K171897 · Cook Incorporated · Aug 2017
True Form Reshapable Guide Wire
K170532 · Merit Medical Systems, Inc. · Jul 2017
Firebow Wire Torque Assist Device
K170684 · Vesatek, LLC · Jun 2017